TOP STORIES

• BUSINESS Gilead Japan Rolling Up Its Sleeves for Foray into Oncology/Inflammation Market
  March 14, 2018

• TRENDS Merck Deal Could Pave Way for Eisai to Hit 800 Billion Yen Sales Target in FY2020
  March 13, 2018

• BUSINESS Eisai Bags Up-to-US$5.76 Billion Lenvima Alliance with Merck
  March 9, 2018

• BUSINESS Foreign Drug Makers Increased Market Share to Over 60% among Top 20 Makers in 2017
  March 9, 2018

• BUSINESS Torii’s Futhan to Get 43.4% Price Cut in April, Urinorm 24.6%: Top 5 Product Survey
  March 8, 2018

• BUSINESS Mid-Sized Japan Makers to Take Heaviest Hit from April Price Cut, Bigger Peers See Smaller Reductions: Jiho Survey
  March 7, 2018

• REGULATORY Winners and Losers of New PMP Criteria: Januvia Earns 1st Premium while Xarelto, Humira Miss It
  March 6, 2018

• REGULATORY 314 APIs Eligible for Price Maintenance Premium in FY2018, Down from 416
  March 5, 2018

• REGULATORY Opdivo Faces 23.8% Price Cut as Slew of Reduction Rules Apply; Nexium Down 16.1% on Huge Seller Slash
  March 5, 2018

• BUSINESS Japan Ethical Drug Sales Slip 1.0% in 2017, Harvoni Drops Out of Top 10 List: IQVIA
  March 2, 2018

• BUSINESS Despite Solid Mainstays, Pfizer Japan’s FY2017 Sales Down 6.6% on LLPs
  March 2, 2018

• ACADEMIA Nephrology Society Compiles New Drug Development Guidelines for Advanced CKD; Will Guidelines for Early-Stage CKD Follow?
  March 1, 2018

• BUSINESS Kissei Makes Full Foray into IBD Arena with Rectabul, Set to Enrich “Unmet Needs” Portfolio
  February 27, 2018

• BUSINESS Nomura Picked as Next Chief of Sumitomo Dainippon, Vows to Build Peripheral Healthcare Biz
  February 26, 2018

• REGULATORY Shionogi’s Single-Dose Flu Med Gets Accelerated OK
  February 26, 2018

• TRENDS Countering Abilify Cliff, Otsuka Sees New Drug Franchise Set Stage for Growth Path
  February 23, 2018

• ACADEMIA Major Drug Makers to Join in AMED Project to Develop “Organs on Chips” as New Tools for Drug Discovery
  February 22, 2018

• BUSINESS Aducanumab Trial Tweak “Common Decision” to Boost Statistical Confidence: Biogen CEO
  February 21, 2018

• BUSINESS Takeda’s Specialty Biz Unit Most Likely to Handle GI Meds, Entyvio Launch Apparently Eyed
  February 20, 2018

• REGULATORY Turning Point for Blood Products? Discussions on Basic Policy on Blood Law Moving Ahead
  February 20, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 149
• 150
• 151
• 152
• 153
• 154
• 155
• 156
• 157
• …
• Next ›
• 最終 »